Rg. Johnson et al., LIDOCAINE PROPHYLAXIS IN CORONARY REVASCULARIZATION PATIENTS - A RANDOMIZED, PROSPECTIVE TRIAL, The Annals of thoracic surgery, 55(5), 1993, pp. 1180-1184
Life-threatening ventricular ectopy can occur after cardiac operations
. The actual incidence of ventricular ectopy and the ability to preven
t it by the routine prophylactic use of lidocaine hydrochloride have n
ot been established. We performed a double-blind, randomized, prospect
ive trial involving 109 patients undergoing elective coronary artery r
evascularization. Patients received either lidocaine (n = 54) or a pla
cebo (n = 55) after separation from bypass. A Holter monitor was affix
ed to each patient for subsequent review, and bedside intensive-care m
onitors with alarms were used for ''real-time'' surveillance. The code
was broken when potentially malignant ventricular ectopy or side effe
cts attributable to the study drug were noted. Three lidocaine patient
s and 2 placebo patients were dropped from the study because of hemody
namic instability or bleeding. Of the remaining 104 patients, the code
was broken in 12 (24%) of the 51 in the lidocaine group (9 for ectopy
and 3 for mental status changes) and 10 (19%) of the 53 in the placeb
o group (all for ectopy) (p = not significant). Twenty-four-hour Holte
r monitor evaluation demonstrated occasional ventricular ectopy in all
patients and nonsustained ventricular tachycardia in 28% in the lidoc
aine group and 48% in the placebo group (p = not significant). The mea
n number of runs of ventricular tachycardia per patient was 0.53 in th
e lidocaine group and 1.6 in the placebo group (p = 0.035). There were
no significant differences in terms of other ventricular ectopy, morb
idity, or mortality. No ventricular fibrillation occurred in either gr
oup. We conclude that although prophylactic administration of lidocain
e may decrease the incidence of nonsustained ventricular tachycardia i
n patients undergoing routine coronary revascularization, there is no
apparent clinical benefit to such a strategy. Lidocaine should be used
for treatment of high-grade ventricular ectopy rather than as prophyl
axis.